Recombinant multi-species RNF40 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF40 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene contains a RING finger, a motif known to be involved in protein-protein and protein-DNA interactions. This protein was reported to interact with the tumor suppressor protein RB1. Studies of the rat counterpart suggested that this protein may function as an E3 ubiquitin-protein ligase, and facilitate the ubiquitination and degradation of syntaxin 1, which is an essential component of the neurotransmitter release machinery. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2011]
The Alternative Names of target: 95 kDa retinoblastoma-associated protein (RBP95),BRE1-B,BRE1B,E3 ubiquitin-protein ligase BRE1B,RBP95,RING finger protein 40,RING-type E3 ubiquitin transferase BRE1B,RNF40,Rnf40,STARING,mKIAA0661

Target products collectionGo to RNF40 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13933-Ag-1/ GM-Tg-hg-IP13933-Ag-2 Human RNF40 protein Human
GM-Tg-rg-IP13933-Ag-1/ GM-Tg-rg-IP13933-Ag-2 Rat RNF40 protein Rat
GM-Tg-mg-IP13933-Ag-1/ GM-Tg-mg-IP13933-Ag-2 Mouse RNF40 protein Mouse
GM-Tg-cynog-IP13933-Ag-1/ GM-Tg-cynog-IP13933-Ag-2 Cynomolgus/Rhesus macaque RNF40 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13933-Ag-1/ GM-Tg-felg-IP13933-Ag-2 Feline RNF40 protein Feline
GM-Tg-cang-IP13933-Ag-1/ GM-Tg-cang-IP13933-Ag-2 Canine RNF40 protein Canine
GM-Tg-bovg-IP13933-Ag-1/ GM-Tg-bovg-IP13933-Ag-2 Bovine RNF40 protein Bovine
GM-Tg-equg-IP13933-Ag-1/ GM-Tg-equg-IP13933-Ag-2 Equine RNF40 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13933-Ag-1/ GM-Tg-hg-IP13933-Ag-2; GM-Tg-rg-IP13933-Ag-1/ GM-Tg-rg-IP13933-Ag-2;
GM-Tg-mg-IP13933-Ag-1/ GM-Tg-mg-IP13933-Ag-2; GM-Tg-cynog-IP13933-Ag-1/ GM-Tg-cynog-IP13933-Ag-2;
GM-Tg-felg-IP13933-Ag-1/ GM-Tg-felg-IP13933-Ag-2; GM-Tg-cang-IP13933-Ag-1/ GM-Tg-cang-IP13933-Ag-2;
GM-Tg-bovg-IP13933-Ag-1/ GM-Tg-bovg-IP13933-Ag-2; GM-Tg-equg-IP13933-Ag-1/ GM-Tg-equg-IP13933-Ag-2
Products Name RNF40 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RNF40
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RNF40 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.